Variant NM_000492.4:c.4046G>A
Name | NM_000492.4:c.4046G>A |
Protein name | NP_000483.3:p.(Gly1349Asp) |
Genomic name (hg19) | chr7:g.117304824G>A UCSC |
#Exon/intron | exon 25 |
Legacy Name | G1349D |
Class | disease-causing |
Subclass | CF-causing |
WT sequence | GATGGGGGCTGTGTCCTAAGCCATG G CCACAAGCAGTTGATGTGCTTGGCT |
Mutant sequence | GATGGGGGCTGTGTCCTAAGCCATG A CCACAAGCAGTTGATGTGCTTGGCT |
dbSNP rs193922525 |
Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
IVA | yes | yes | no | yes |
TEZ-IVA | yes | no | yes | no |
ELX-TEZ-IVA | yes | no | yes | no |
clinical and functional data are provided by Vertex
No patient found in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 2 |
---|---|
CF | 1 |
CFTR-RD | 1
|
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CF | 340 | heterozygote | VUS1 - Cis CF-causing - Trans |
CBAVD | 403 | heterozygote | VUS1 - Cis CFTR-RD-causing - Trans |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|